# Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma

> **NCT01944982** · PHASE1,PHASE2 · TERMINATED · sponsor: **Hospital Infantil Universitario Niño Jesús, Madrid, Spain** · enrollment: 7 (actual)

## Conditions studied

- Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma

## Interventions

- **BIOLOGICAL:** Expanded haploidentical natural killer cells (NKAEs)

## Key facts

- **NCT ID:** NCT01944982
- **Lead sponsor:** Hospital Infantil Universitario Niño Jesús, Madrid, Spain
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** The low recruitment rate makes it very difficult to complete the study within a reasonable period of time.
- **Last updated:** 2016-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01944982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01944982, "Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01944982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*